2 July 2018 - Deborah Wilkes
Archived
Novartis plans to spin off its Alcon eyecare devices division into a separately-traded standalone company with 2017 sales of around USD6.7 billion.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.